Bio-Thera Solutions

Bio-Thera Solutions, based in Guangzhou, China, is a pharmaceutical company. Bio-Thera Solutions is a Guangzhou-based biopharmaceutical company that develops and markets antibody therapeutics, including approved biosimilars and pipeline candidates for cancer and autoimmune disease. On ClinicalTrials.gov it is the lead sponsor of 3 recruiting or active phase 2 and phase 3 interventional cancer trials (1 in phase 3), testing BAT8008, BAT1308, BAT8010 and BAT1006 in cervical cancer. The largest, NCT06123884 (BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer), plans to enrol 526 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.